EP Patent

EP2123255A1 — Pharmaceutical composition containing fine particle oil-based suspension

Assigned to Aska Pharmaceutical Co Ltd · Expires 2009-11-25 · 16y expired

What this patent protects

A pharmaceutical composition comprising a suspension of medicinally-active ingredient microparticles having a mean particle diameter of 20 µm or smaller in a base oil which can achieve extremely high intestinal absorption and bioavailability especially when the medicinally-active…

USPTO Abstract

A pharmaceutical composition comprising a suspension of medicinally-active ingredient microparticles having a mean particle diameter of 20 µm or smaller in a base oil which can achieve extremely high intestinal absorption and bioavailability especially when the medicinally-active ingredient is hardly water-soluble.

Drugs covered by this patent

Patent Metadata

Patent number
EP2123255A1
Jurisdiction
EP
Classification
Expires
2009-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Aska Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.